Search

Charles River Laboratories International Inc

Suletud

SektorTervishoid

298.97 0.96

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

287.75

Max

298.95

Põhinäitajad

By Trading Economics

Sissetulek

14M

-760K

Müük

8.2M

1B

Aktsiakasum

3.02

Kasumimarginaal

-0.076

Töötajad

18,300

EBITDA

87M

151M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

-3.57% downside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

4. nov 2026

Turustatistika

By TradingEconomics

Turukapital

2.5B

14B

Eelmine avamishind

298.01

Eelmine sulgemishind

298.97

Uudiste sentiment

By Acuity

50%

50%

150 / 340 Pingereas Healthcare

Charles River Laboratories International Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

24. aug 2026, 19:16 UTC

Correlated Moves

Charles River Laboratories is trading roughly flat amid a notable decline in Agilent Technologies. Market focus is on upcoming events, including a Federal Reserve speech.

21. aug 2026, 23:01 UTC

Charles River Laboratories shares declined in after-market trading, amid broader market volatility tied to rising U.S. Treasury yields and inflation concerns.

20. aug 2026, 19:41 UTC

News

Charles River Laboratories partners with Medigen to develop a multivalent enterovirus vaccine, supporting regulatory readiness and non-clinical studies. Shares are trading higher.

19. aug 2026, 23:56 UTC

Charles River Laboratories shares are higher in after-market trading, reaching a notable increase since Wednesday's close and positioning near the upper end of its one-month range.

17. aug 2026, 19:26 UTC

Charles River Laboratories shares are higher today, continuing an upward trend since Friday's close. The stock remains near the top of its one-month trading range.

14. aug 2026, 19:46 UTC

Charles River Laboratories shares are lower amid broader market declines following a drop in U.S. retail sales, indicating potential weakening consumer demand.

13. aug 2026, 19:52 UTC

Correlated Moves

Charles River Laboratories shares are lower today amid rising jobless claims and volatility, reflecting a decline since Wednesday's close.

12. aug 2026, 20:51 UTC

Charles River Laboratories is higher in after-market trading, reflecting positive momentum despite no specific news. Broader market dynamics appear to support this resilience.

11. aug 2026, 19:56 UTC

Charles River Laboratories International Inc. shares are trading higher today, maintaining a position above the 20-day moving average amid routine price movements.

10. aug 2026, 19:16 UTC

News

Charles River Laboratories shares rise as TD Cowen and Mizuho raise price targets to $300 and $264, respectively. The stock shows notable strength since Friday.

7. aug 2026, 19:51 UTC

News

Morgan Stanley raised its price target on Charles River Laboratories to $300, maintaining an Overweight rating as shares move higher since Thursday's close.

6. aug 2026, 22:51 UTC

Shares of Charles River Laboratories International Inc. are lower in after-market trading, continuing a decline from Thursday's close despite being above its 20-day moving average.

5. aug 2026, 23:56 UTC

Charles River Laboratories is higher in after-market hours, recovering from session lows. Broader market sentiment is affected by a disappointing ADP employment report.

4. aug 2026, 19:16 UTC

Correlated Moves

Charles River Laboratories is rising amid positive momentum in the small-cap market, supported by a drop in crude oil prices that eases inflation concerns.

3. aug 2026, 22:06 UTC

Charles River Laboratories shares are slightly higher in after-hours trading, supported by stronger-than-expected manufacturing data showing a rise in the PMI for July.

31. juuli 2026, 19:46 UTC

Correlated Moves

Charles River Laboratories reported first-quarter revenue of $1.02 billion and adjusted EPS of $2.06, but shares are lower amid broader market declines.

30. juuli 2026, 23:01 UTC

Shares of Charles River Laboratories are higher in after-market trading, reaching a peak above Thursday's close and remaining strong relative to recent trends.

29. juuli 2026, 19:18 UTC

Correlated Moves

Charles River Laboratories is lower today amid broader market declines and investor caution ahead of the Federal Reserve's monetary policy announcement.

28. juuli 2026, 18:02 UTC

Charles River Laboratories is trading higher today, continuing a strong rally since Monday. The stock remains above its 20-day moving average.

27. juuli 2026, 17:36 UTC

News
Correlated Moves

Charles River Laboratories is trading lower today, reflecting a decline since Friday. The company announced a collaboration with Arovella Therapeutics for GMP sequencing services.

23. juuli 2026, 00:01 UTC

Charles River Laboratories is higher in after-hours trading, maintaining a cumulative gain since Wednesday amid no specific news to explain the movement.

22. juuli 2026, 22:01 UTC

Charles River Laboratories shares are higher in after-hours trading, reflecting a notable increase since Wednesday's close and positioning above the 20-day moving average.

21. juuli 2026, 21:01 UTC

Charles River Laboratories shares moved lower in after-market trading, continuing a steady decline since Tuesday's close amid broader market concerns.

20. juuli 2026, 21:01 UTC

Shares of Charles River Laboratories International Inc are lower in after-market trading, continuing a trend of declines with no specific news to explain the movement.

Võrdlus sarnastega

Hinnamuutus

Charles River Laboratories International Inc Prognoos

Hinnasiht

By TipRanks

-3.57% langus

12 kuu keskmine prognoos

Keskmine 284.64 USD  -3.57%

Kõrge 310 USD

Madal 219 USD

Põhineb 13 Wall Streeti analüütiku instrumendi Charles River Laboratories International Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

13 ratings

11

Osta

2

Hoia

0

Müü

Sentiment

By Acuity

150 / 340 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Charles River Laboratories International Inc

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.
help-icon Live chat